Cubist Pharmaceuticals Inc. (CBST) Tops Q1 EPS by 27c
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Basic net (loss) income per common share (in shares): 75.83M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Basic net (loss) income per common share (in shares): 75.83M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Cubist Pharmaceuticals Inc. (NASDAQ: CBST) reported Q1 EPS of $0.55, $0.27 better than the analyst estimate of $0.28. Revenue for the quarter came in at $162.5 million versus the consensus estimate of $155.78 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
